SIGA
SIGA Technologies, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-10
Figures on this page computed 2026-11-08 12:24 UTC
Last close
3.15USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-03-10
9.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-03-10
40.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-06
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-06
24.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
45.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-K for 2025, filed 2026-03-10
0.004Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
- 10-K for 2025, filed 2026-03-10
- 10-Q for 2025, filed 2026-08-06
19.4%Dividend yield
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Growth is the furthest below its sector's middle: 0.14 against 0.47 on the market's range.
Against its rival
lens 4 of 9Measure by measure
behind on 1 of 3- Profit on each unit of sales24.6%-28.4%Ahead
Higher is better here.
- Return on the capital it uses40.7%n/an/a
Higher is better here.
- Sales growth over five years-5.4%14.7%Behind
Higher is better here.
- Debt against equity0.00n/an/a
Lower is better here.
- Gross margin68.6%29.7%Ahead
Higher is better here.
- Price against earnings9.4xn/an/a
Lower is better here.
The first column is this company and the second is the one it is set against. A measure only one of the two reports is left at n/a rather than counted as a win.
Against Organigram Global Inc., SIGA is behind on 1 of 3 measures.
Against Organigram Global Inc., SIGA is behind on 1 of 3 measures.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-03-10
Profit on each unit of sales24.6%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
Return on the capital it uses40.7%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
Sales growth over five years-5.4%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
Debt against equity0.004
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
Gross margin68.6%
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD
Price against earnings9.4x
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001437749-26-007557
- Reported in
- USD